FATE
Fate Therapeutics, Inc. · Healthcare
CFO Edward J Dulac III sold $38K of Fate Therapeutics, Inc.
Sold$38,414
$5.24Price
7,331Shares
−5%Stake
What FATE did after the filing
- The stock from Wed, Jan 11 close, $5.72
- +1.2%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Feb 24 close.
Traded Tue, Jan 10. Filed Wed, Jan 11, 11:06 AM ET, during the session. Returns use the Jan 11 close and the Feb 24 close. Not investment advice.